Apollo Global Management is in discussions to acquire Johnson & Johnson's orthopedics division, which could be worth around twenty billion dollars. In addition to this, Johnson & Johnson is contemplating the option of spinning off this unit into a separate public entity. This strategy aligns with the company's aim to concentrate on more lucrative healthcare areas, reflecting the growing private equity interest in the healthcare industry.